Pannke will take over the responsibility of all of SCHOTT’s global M&A efforts, advising on the implementation of our corporate acquisition strategy and managing the commercial, financial and legal advisors during the entire process. She will report directly to Dr. Jens Schulte, SCHOTT’s CFO and member of its Management Board.
“We are pleased to have Ada join our team at SCHOTT,” Dr. Schulte commented. “This newly created position underscores our strategic plans to grow through acquisitions on top of our organic growth.
“As previously reported, we are looking to expand our acquisition pipeline with companies that would add value to the diverse SCHOTT portfolio, which reaches from astronomy applications to glass-ceramic surfaces in the kitchen to medical devices. With that in mind, we are particularly interested in companies which offer complementary glass types, composites and other related services, with sales up to €150 million.”
Pannke came to SCHOTT from the M&A advisory firm Lincoln International AG in Frankfurt, where she held the position of director and head of healthcare sector team for the DACH region. Prior to that, she was a director M&A at German Merck Group covering the Healthcare, Life Sciences and Performance Materials sectors. Previously she was VP in Lincoln International’s Automotive & Industrials M&A practice.
Earlier she held positions of increasing responsibility in corporate finance with Banco Bilbao Vizcaya Argentaria SA, JP Morgan Cazenove Ltd., and B.Metzler GmbH, all in Germany. She started her career at Deloitte & Touche’s Transaction Services practice as an analyst in the private equity coverage group.